Riyu's Back File 2011

When Miyazaki said this, he was really a little angry, and he almost pointed to the noses of the people like Shiono Yoshi and Ono Pharmaceutical who were generally useless.

Although Miyazaki Sosuke said very vaguely, he still has to continue.

"If you can't sell others, we have to find the reason. If we can't find the reason, we have to find a way to dig out the other person and let others explain the reason to you. If you can't learn, copy, and if you can't copy, analyze. Big superstition, one is superstitious qualifications, and the other is superstitious experts. I am better, only superstitious about data. Also, do you executives, do not consider the impact when making plans? Provoked opposition from so many people, isn’t it? Haven't done internal research? Don't tell me any nonsense that the market and R&D cannot have both. The reform plan will not work, then find a way to make a more powerful new plan."

At this point, no one below dared to say anything.

Miyazaki Cangsuke not only scolded the conservative R&D staff, but also scolded Tamaki Tai and others who were eager for quick success.

Pascal Soliot and Tamaki Masao are professional managers hired by Miyazaki Sosuke. They have different division of labor and different career development routes, but they are all equally powerful.Of course, Pascal Soliot may be more powerful, otherwise the position will not be higher, he is the CEO of the group.

"Nippon Biopharmaceutical Group is a company founded by me. You can say that it was born on the basis of Ono Pharmaceutical and Shiono Yoshitaka, but fundamentally speaking, we are still a new company.

I don't care what you people think. Since we are now going to be the pharmaceutical industry, we want it in the Japanese market and we want it in the foreign market.R&D can't be left behind, but I don't want to see billions of dollars invested in it. You can make me a semi-finished product.Talking about you Shiono Yoshihide people."

Miyazaki Sosuke decided to clarify thoroughly, temporarily suppress the struggle between the two factions, and deal with these disputes with a developmental perspective.

"From today onwards, there are no so-called factional disputes in the Japan Life Pharmaceutical Group, and there is no difference in background. Whether you are doing research and development, or doing marketing, you are from Goldman Sachs, or you have been staying in drug research and development. Both have to cheer me up 200%.

The direction of the group has been to do great health from beginning to end, but now it is only a small step.For prescription drugs, we only have more than 30 products on the market. We will do everything in the non-prescription drug market, the US market, the Chinese market, and even the medical service market. Ultimately, we must find a perfect fit in the balance, from birth to death , And even burial business, pass kill!"

### Chapter 153 Who do the three wives love most?###

Although Miyazaki Sosuke's general health strategy has been in place, he has never revealed the complete idea of ​​how to do it.But now, in order to appease everyone, he still revealed a little.That is to make a complete industrial chain, from birth to death, the whole process is killed.

"Chairman, I believe that your vision is indeed a great idea for the development strategy of all fields. However, as a company, our development direction must be light and focused. Currently, the top three in the world Ten pharmaceutical companies, their development direction, except Gilead relying on storytelling, everyone else is learning Ruihui, as a platform, this is what we need to learn. The most urgent thing is to use our resources to expand our... ...!"

This was Pascal Soriot, the CEO of the group company, speaking. It was his turn, and he cracked and talked for ten minutes and couldn't stop.

The CEO of the marketing department is very eloquent and realistic.No matter how the pharmaceutical industry develops, it is still a company in the final analysis, and it still needs to make its financial statements look good.

So, if you want turnover and profit, you will undoubtedly learn from Pfizer, a leader, to reduce your investment in new drug development and expand your market share. All products are purchased from other drug manufacturers.As long as there is a platform on hand, even if the drug itself is not so good, it can still get good sales.

In this way, it can not only effectively reduce the investment risk of new drug development, but also ensure that the group's profits will not drop significantly due to the failure of several projects.You know, the output of a new drug, from research and development to the market, after investing more than one billion U.S. dollars, is not a small minority.Therefore, few pharmaceutical companies develop new drug projects alone, which is too risky.

In the current market, the mainstream practice of pharmaceutical companies is that many large pharmaceutical companies buy semi-finished patented drugs from medium-sized pharmaceutical companies for secondary development, or jointly develop new drugs with these companies to reduce their own investment and risk. , And then use the global market in hand to quickly distribute goods and recover profits.

Therefore, the saying that it is a dead end in R&D is a cruel reality.

R&D pharmaceutical companies have no stock price or financing.Not only are mid-sized pharmaceutical companies like Shiono Yoshi and Ye Pharmaceutical, but even mid-sized R&D pharmaceutical companies in the United States and Europe have extremely low price-earnings ratios, which are not as high as the price-earnings ratios of related medical device companies.

Those who do hardware are not as good as those in the market, just like Qualcomm and Cisco are not as good as Amazon and Microsoft to attract investors.

"Well. Suppose I now have three wives, each of whom is a beautiful woman with a national beauty and charm." Miyazaki Cangsuke put up his hand on the large desk, propped his chin and looked at the crowd, suddenly raised a wind. Unrelated topics.

"Huh? What do you mean?" Pascal Soriot didn't understand Miyazaki's meaning. How many wives do you care about him?Although it sounds very enviable.

"I mean, I know which one of these three wives is my favorite, and I know it all in my heart. But if you ask me, I say that I won't come out if I am killed." Miyazaki Cangsuke tried his best not to be more straightforward.

"Because I am the husband of this family, everything I do is to try my best to make them happy and maintain the balance of the family, instead of trying to provoke them to split. So, don’t think about asking me to support one wife to bully others. People, unless I want to leave now. Are you the reason?"

Pascal Soriot was a little dizzy to hear, and Miyazaki Aosuke's English was so fast that he had not escaped from the other party's misunderstanding.

"Similarly, as the executive director and chief executive officer of this group company, what you have to do is not to choose which side to support, but to try to achieve a balanced level. You need to tell yourself that every wife is very Beautiful, you are all you, and you are them. Therefore, for the development goals of the big health field, even if you are opened, you should not stand up and stand in line to support one side. Are you right?"

Miyazaki Cangsuke faced this somewhat outspoken CEO and had no choice but to preach and persuade him carefully.

"Even if you take a 10,000 step back, this kind of strategic disagreement, you, as the head of our board of directors, should not choose easily. Even if we finally have no choice, we have taken the market-oriented route and invested in research and development. If it is lowered, what you have to do is still try to maintain a balance as much as possible, and even throw the pot on the head of our board. If your subordinates ask, you can completely shirk the decision of our board."

"Chairman, yours makes sense." Pascal Soriot heard Miyazaki's addition and thought about it. He also had to admit that the other party was justified. This time he stood in a rush because he was too impatient and tried to produce quickly. Achievements caused the division within the group.

But there is no way. Suddenly, he was dug into the Bensheng Pharmaceutical Group by the high price of Miyazaki Aosuke's double salary, and he was entrusted with the important task to become the CEO. Pascal Soriot's mentality of trying to make achievements is understandable.

During the previous interview, Pascal Soriot made a bold statement with several board members that to double the sales of Bensheng Pharmaceutical Group in five years, this is not a simple goal that can be achieved.

"So, the problem we are facing now is very simple. The vice president of Teyogi is responsible for research and development and product manufacturing. The vice president of Tamaki will be responsible for market development, especially for the Chinese market. Pascal Soriot, your mission is Responsible for the center coordination, so that the will of the board of directors can be well implemented within the company." Miyazaki Aosuke here, also specifically mentioned his own general Tamaki Masada, so that he can be refreshed in the development of the Chinese market.

"What kind of person I am, I think many people are very clear. If there are people who are not familiar with me, you can ask Director Hill, she will be responsible for the communication between me and everyone in the future. My style of doing things has always been simple Directly, give everyone a goal, and then encourage everyone to complete it together.

If you can do it, it’s not a problem to get a promotion or raise your salary.It is really a matter of objective reasons that caused the goal to be impossible to complete, and I will not blame you.But if you let me know that you don’t fit my style or the style I built for the team, either you go or I go.Of course, the high probability is still you go."

At this point, Miyazaki Sosuke paused, and everyone laughed after hearing it. The original atmosphere was somewhat serious, but it was also made lighter by Miyazaki's words.

"This is my style. The Life Group is a company that will do a big health industry. We have to be tolerant and cooperate with each other."

###One hundred and fifty-fourth chapters don't say love easily ###

Seeing that the people below had nothing to say, Miyazaki Sosuke's speech not only did not end, but was more interested.

"It doesn’t matter whether you are reformers or conservatives, whether you are in the market or in research and development, just let the people below fight for this kind of thing. You senior management must not have this kind of disagreement. Everyone must be unified. Thinking, let the Life Group become a dominant health service provider in all fields, this is our strategic development goal."

With this much, Miyazaki Cangsuke thought it could be simpler, he was afraid that these people would still not understand his own ideas.

"The team below are all your wives, just like I have three wives. We are husbands, don't expose the idea of ​​who you like best in front of them, even if your wife is really crazy Some things can be done, but not, really, it is an act of seeking death.

There is also a reason for managing a company. Before it fails and proves that a certain road is really unworkable, it is easy to give up or say something similar. How can such a leadership manage the entire team?

Nothing else, we are the leading pharmaceutical companies such as Pfizer and GlaxoSmithKline. Although they are already developing in the direction of platformization, if they separate the R&D business now and establish a new company, the parent company Just doing the market, this is a pure act of death.

If their markets and channels are crushed, they will not even have an objective chance of comeback, a company has no ambition to establish an ecosystem, and its style cannot be improved. Such a company will never be a truly top company."

After patiently persuading him, Miyazaki Cangsuke started to pour chicken soup on the executives after explaining the truth.Chicken soup, no matter where it is, you will need it. This is nutrition.It's just that different occasions require different chicken soup seasonings. For example, now he is going to draw cakes for executives, the bigger the better, and the cakes must look edible.

"My words are from my heart. For a long time, I have always felt that this kind of factional dispute within a company is very boring. It is like in a family. If wives are jealous, fight each other, and slander each other, then It can only be clear that there is a problem with being a husband."

Miyazaki Sosuke’s remarks were addressed to two leaders, CEO Pascal Soriot and Teyogi. The top executives of your two companies did not want to solve this meaningless dispute, but stood in line to support. Let this kind of internal friction rise to the level of the entire group, and have the face to come to the palace, and let Miyazaki Cangsuke express himself, it is simply frantic and rebellious.

After these words, Miyazaki Sosuke raised his wrist and looked at the time. He felt that the time was almost up, so he asked a group of people to follow him to the meeting room.

"Let's go, a few big leaders. Now we have to go to the meeting to help you draw an end to this dispute and unify your thoughts. It doesn't matter what the people below think, at least we high-level leaders must clearly understand that, Don’t be the best person, unless you just want to serve a wife, a business, and a team whole-heartedly."

Seeing Miyazaki Sosuke’s actions, the person from the president’s office opened the door of the office and let him go out in the first place. Then CEO Pascal Soliot and Vice Chairman Masanori Mochida followed suit and sorted out their clothes. Closed the door.

The battle over the life-and-death route of the Biopharmaceutical Group should come to an end.

In fact, in the heart of Miyazaki Sosuke, he approves of CEO Pascal Soliot's ideas, otherwise he would not hire him for a high salary as the group CEO.

As a rising star, the Biopharmaceutical Group now has an annual turnover of only tens of billions of dollars after integration, making it a second-tier pharmaceutical company.

If we continue to develop according to Shiono Yoshiwa’s old corporate management thinking, it will be difficult for the Biopharmaceutical Group to achieve the top positions in this industry, even if the upcoming new drugs have tens of billions of sales. The potential of the amount is at most competing for the top ten.

Therefore, instead of such a conservative development, it is better to concentrate all resources on the market and sales department that are still relatively advantageous, and vigorously build their own marketing capabilities.

In fact, this idea is correct, but there is a limit to be added, that is, it is correct before 2012.After 2012, the saturated competition in the existing pharmaceutical market and the rapid spread of aging in many countries have forced pharmaceutical companies to find other ways.

In the future, leading pharmaceutical companies will not only develop from the lucrative prescription drug market to the over-the-counter drug market, but even make vaccines, medical devices, and health care products. Even in the Chinese medicine business, many pharmaceutical companies have to develop the Chinese market. Tried.Tomorrow's pharmaceutical companies, in order to expand their business, can be said to do everything.

The current Sino-Life Group wants to reduce its R&D business, or even separate it out to establish a special new company. It is almost like Pfizer’s announcement that it will sell Viagra's patents. R&D business not only cannot be reduced, but must continue to expand.Because once you give up this kind of thing, it's too difficult to pick it up again.